<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>The presence of antiphospholipid (aPL) antibodies and <z:e sem="disease" ids="C0085278" disease_type="Disease or Syndrome" abbrv="">antiphospholipid syndrome</z:e> (APS) was researched in 57 children and adolescents with <z:hpo ids='HP_0002725'>systemic lupus erythematosus</z:hpo> (SLE) </plain></SENT>
<SENT sid="1" pm="."><plain>The frequency of aPL antibodies was 75.4% (anticardiolipin 70.2% and <z:e sem="disease" ids="C0024138,C0024141,C0024131,C0409974" disease_type="Disease or Syndrome" abbrv="">lupus</z:e> <z:chebi fb="3" ids="50249">anticoagulant</z:chebi> 29.1%) </plain></SENT>
<SENT sid="2" pm="."><plain>The positivity for these antibodies fluctuated during the course of the disease </plain></SENT>
<SENT sid="3" pm="."><plain>No association was found between aPL antibodies and clinical or laboratory manifestations or the autoantibodies studied, nor with the activity or gravity of the SLE </plain></SENT>
<SENT sid="4" pm="."><plain>APS was diagnosed in 14% of the cases (eight patients), on average three years after the diagnosis of SLE </plain></SENT>
<SENT sid="5" pm="."><plain>Four patients had <z:hpo ids='HP_0004420'>arterial thrombosis</z:hpo> (<z:hpo ids='HP_0001297'>stroke</z:hpo>, three; <z:e sem="disease" ids="C0007787" disease_type="Disease or Syndrome" abbrv="tia|TIA|T.I.A.">transient ischaemic attack</z:e>, one; <z:hpo ids='HP_0100576'>amaurosis fugax</z:hpo>, two; renal, one), one presented with <z:hpo ids='HP_0002625'>deep vein thrombosis</z:hpo> (DVT) and three had involvement of small calibre vessels (<z:hpo ids='HP_0010885'>osteonecrosis</z:hpo>, two; <z:e sem="disease" ids="C0026976" disease_type="Disease or Syndrome" abbrv="">transverse myelitis</z:e>, one) </plain></SENT>
<SENT sid="6" pm="."><plain>Recurrences were observed in three of the eight cases (37.5%), with a mean interval of 13 months between the events </plain></SENT>
<SENT sid="7" pm="."><plain>The presence of APS was associated with <z:hpo ids='HP_0001878'>haemolytic anaemia</z:hpo>, <z:hpo ids='HP_0001882'>leukopenia</z:hpo>, <z:hpo ids='HP_0001873'>thrombocytopenia</z:hpo>, <z:hpo ids='HP_0001928'>coagulation abnormalities</z:hpo>, ischaemic <z:hpo ids='HP_0001297'>cerebrovascular accidents</z:hpo>, <z:hpo ids='HP_0100576'>amaurosis fugax</z:hpo>, <z:hpo ids='HP_0010885'>osteonecrosis</z:hpo> and <z:hpo ids='HP_0006515'>interstitial pneumonitis</z:hpo> </plain></SENT>
<SENT sid="8" pm="."><plain>A negative association was observed between APS and the presence of anti-Ro antibodies </plain></SENT>
</text></document>